Multiple Sclerosis Journal · 2003 · 21 citations · 9 references
Life SciencesBiochemistryNeurologyClinical BiochemistryNeuroimmunologyProteomicsBottom-up ProteomicsClinical ProteomicsMass Spectrometry-based ProteomicsMultiple SclerosisProtein SeparationDiagnostic ProteomicsDisease ProteomicsPeptide Mass SpectrometryPeptide SeparationPeptide-mass FingerprintingProtein Analysis In Body FluidsProtein RecoveryTwo-dimensional Gel Electrophoresis
Proteomics combines two-dimensional gel electrophoresis and peptide mass fingerprinting and can potentially identify a protein(s) unique to disease. Such proteins can be used either for diagnosis or may be relevant to the pathogenesis of disease. Because patients with multiple sclerosis (MS) have increased amounts of immunoglobulin (Ig) G in their cerebrospinal fluid (CSF) that is directed against an as yet unidentified protein, we are applying proteomics to MS CSF, studies that require optimal separation of proteins in human CSF. We found that recovery of proteins from CSF of MS patients was improved using ultrafiltration, rather than dialysis, for desalting. Resolution of these proteins was enhanced by acetone precipitation of desalted CSF before electrophoresis and by fractionation of CSF using Cibacron Blue sepharose affinity chromatography. Improved protein recovery and resolution will facilitate excision from gels for analysis by peptide mass fingerprinting.
9
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Andrej Shevchenko, Matthias Wilm, Ole Vorm et al. · Analytical Chemistry · 1996 · 9.1K citations
Alessandra Castegna, Michael Y. Aksenov, Marina Aksenova et al. · Free Radical Biology and Medicine · 2002 · 578 citations